ATLANTA, GA – – (Globe Newswire – March 5, 2025) – – A shareholder class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts regarding Maravai’s business, operations, and prospects, including allegations that: (1) Maravai lacked adequate internal controls over financial reporting related to revenue recognition; (2) as a result, the Company inaccurately recognized revenue on certain transactions during fiscal 2024; and (3) its goodwill was overstated.

If you bought shares of Maravai between August 7, 2024 and February 24, 2025, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/maravai-lifesciences/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is May 5, 2025.